-
The working principle and design requirements of aerobic pond
Time of Update: 2021-06-18
(2) The organic load of the ordinary aerobic pond is lower than the former, and the hydraulic retention time is longer .
(3) The organic load of the advanced treatment aerobic pond is low, and the hydraulic retention time is also short .
-
Metz Tumor Progress Express (Issue 007
Time of Update: 2021-06-04
The results of this study showed that in high-risk locally advanced head and neck squamous cell carcinoma patients, adding avelumab to concurrent chemoradiation did not improve the progression-free survival of patients.
-
J Pediatr: Can physical therapy improve the symptoms of children with functional constipation
Time of Update: 2021-05-31
Recently, in a randomized trial, researchers explored the therapeutic effect of physical therapy combined with conventional treatment compared with conventional treatment alone on functional constipation in children aged 4-17 years in the Netherlands .
-
J Gastroenterology H: Patients with symptomatic cholelithiasis have a significantly increased risk of pancreatic cancer
Time of Update: 2021-05-31
This study confirms that patients with symptomatic cholelithiasis are a risk factor for high incidence of pancreatic cancer, but no matter what intervention is selected for cholelithiasis, the risk of pancreatic cancer is similar.
-
Aliment Pharmacol Ther: elobixibat improves chronic constipation by affecting secreted bile acids
Time of Update: 2021-05-20
Recently, a prospective single-center study explored the effects of elobixibat on the concentration of total bile acids and individual bile acids in feces and changes in the fecal microbiota.
-
Clin Gastroenterol H: Perianal Crohn's disease is associated with poor prognosis
Time of Update: 2021-05-07
Researchers validated specific algorithms to determine fistula-type PCD and distinguished between severe and non-critical diseases through drug use, ICD-9 codes, and perianal surgery.
diagnosisThus, although the immune higher utilization modulator and biological agents, but with a poor prognosis PCD disease, especially in patients with severe PCD .
-
2020 my country's three major terminals and six major markets have 1,643.7 billion drug sales, a year-on-year negative growth of 8.5
Time of Update: 2021-05-02
From the perspective of the sales distribution of the three major terminals that realize drug sales, the public hospital terminal has the largest market share, accounting for 64.
0% in 2020; the retail pharmacy terminal market share in 2020 will account for 26.
-
Pangang Vanadium Titanium (000629.SZ) is expected to increase its net profit attributable to the parent in the first quarter by 98.59% year-on-year to 126.96
Time of Update: 2021-04-24
Pangang Vanadium and Titanium (000629. SZ) released the first quarter of 2021 performance forecast. The company expects that the net profit attributable to shareholders of listed companies will be b
-
The brain health of one-third of people infected with the new crown is affected, and the "Lancet" publication publishes data on 230,000 patients
Time of Update: 2021-04-24
"This is real-world data collected from a large number of patients, which confirms that the diagnosis rate of mental illness after the new crown is high, and it can also cause serious diseases that affect the nervous system (such as stroke and dementia).
-
The disease control rate of 90% mRNA cancer vaccine/Keytruda combination had positive early clinical results
Time of Update: 2021-02-24
mRNA-4157 was used in a phase 1 clinical trial to treat HPV-negative head and neck squamous cell carcinoma (HNSCC) patients with a total remission rate (ORR) of 50% (ORR) and a 9.8-month medium progressive survival (mPFS).
-
Comparison of the two surgical methods of glioblastoma in the temporal lobe
Time of Update: 2021-02-14
Mattias Schneider of Neurosurgery at the University Hospital of Bonn, Germany, and others compared the safety indicators associated with standard surgical removal of glioblastoma of the temporal lobe and excision of the front temporal lobe, and found no significant difference in the effectiveness of the two surgical methods.
-
Tecentriq and Avastin chemotherapy triplets were approved immediately
Time of Update: 2021-02-09
, the Swiss pharmaceutical giant, recently announced that the European Medicines Agency(EMA) Commission on Human Pharmaceutical Products (CHMP) has issued an active review recommending approval of the PD-L1 oncology immunotherapy Tecentriq (atezolizumab) in combination with A vastin, generic name: bevacizumab, beva monoantigen) and chemotherapy (yew alcohol and carpentry), for first-line treatment in patients with metastasis non-squamous non-small cell lung cancer (NSq NSCLC) without EGFR or ALC genomic tumor distortion.
-
October 2019 monthly sugar market supply and demand situation analysis: domestic sugar prices flat slightly higher
Time of Update: 2021-01-20
Internationally, a number of organizations raised the 2019/20 squeeze season global sugar production gap, medium- and long-term international sugar prices are expected to be good, in the short term the global sugar supply is still sufficient, it is expected that the near-term international sugar prices to run smoothly mainly.
-
Alzheimer's and Dementia: LDL cholesterol and urinary glycoside levels predict clinical progress of AD
Time of Update: 2021-01-17
A recent study suggests a nutritional risk index, including levels of omega-3 fatty acids, vitamin D, and homocysteine, that may help identify older people with a reduced risk of cognitive decline who have not yet developed a phenolype of dementia.
-
Eur Radiol: Is there any metastasis of the lymph nodes in front of patients with non-small cell lung cancer
Time of Update: 2021-01-14
Objective: The purpose of this study is to establish the best machine learning (ML) model using 18F-fluorodeoxycycline glucose (FDG) positive electron emission fault scanning/computer fault scanning (PET/CT) to evaluate the metastatic vertical lymph nodes (MedLNs) of non-small cell lung cancer and compare the diagnostic results with 1stdicated results of nuclear medicine physicians.
